The present disclosure relates to a pharmaceutical composition and a health composition including an effective amount of a bay leaf extract as an active ingredient for treatment and prevention of benign prostatic hyperplasia, and a method of treating benign prostatic hyperplasia using the same.

The present disclosure provides methods for treating and preventing foot pain, muscle soreness, inflammation or an inflammatory-related disorder, and itch with the administration of compositions comprising pine resin. Also provided are methods of repelling an insect by applying to a subject composition comprising pine resin.

The present disclosure provides methods for treating and preventing foot pain, muscle soreness, inflammation or an inflammatory-related disorder, and itch with the administration of compositions comprising pine resin. Also provided are methods of repelling an insect by applying to a subject composition comprising pine resin.

The invention relates to a method for treating a skin disorder. In particular, the invention provides a method for treating a skin disorder, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising at least 75% by weight of a main cannabinoid.

The invention relates to a method for treating a skin disorder. In particular, the invention provides a method for treating a skin disorder, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising at least 75% by weight of a main cannabinoid.

The invention relates to a method for treating a skin disorder. In particular, the invention provides a method for treating a skin disorder, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising at least 75% by weight of a main cannabinoid.

The present application relates to compositions and dosage forms comprising propolis and tannic acid (sumac powder), and optionally other ingredients such as cinnamon, clove and/or gum arabic. The present application also relates to the use of such compositions or dosage forms for enhancing or boosting the immune response in subjects, for example subjects suffering from infectious diseases such as COVID-19.

The present application relates to compositions and dosage forms comprising propolis and tannic acid (sumac powder), and optionally other ingredients such as cinnamon, clove and/or gum arabic. The present application also relates to the use of such compositions or dosage forms for enhancing or boosting the immune response in subjects, for example subjects suffering from infectious diseases such as COVID-19.

The present application relates to compositions and dosage forms comprising propolis and tannic acid (sumac powder), and optionally other ingredients such as cinnamon, clove and/or gum arabic. The present application also relates to the use of such compositions or dosage forms for enhancing or boosting the immune response in subjects, for example subjects suffering from infectious diseases such as COVID-19.

The present invention relates to a composition for use as an oral anti-parasitic, the composition comprises one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus Cinnamomum, Eugenia, Eucalyptus or a source of saponin. It also relates to a method of preventing or treating parasitic infection in an animal, the method comprising orally administering to said animal a composition comprising one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus Cinnamomum, Eugenia, Eucalyptus or a source of saponin.